MiR-598-3p functions as a tumor suppressor in pediatric T-cell acute lymphoblastic leukemia
Abstract
Purpose: To investigate the role of miR-598-3p in pediatric T-cell acute lymphoblastic leukemia (T- ALL).
Methods: The expression of miR-598-3p in mononuclear cells isolated from the peripheral blood samples of children with or without T-ALL was assessed using real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Cell viability or proliferation of T-ALL cell lines was evaluated using cell counting kit-8 assay or bromodeoxyuridine staining, respectively. The target gene of miR-598-3p was predicted and validated using luciferase reporter assay, while the underlying mechanism involved in miR-598-3p-mediated T-ALL was determined by western blot analysis.
Results: MiR-598-3p was reduced in the peripheral blood mononuclear cells of T-ALL patients. Ectopic miR-598-3p expression decreased T-ALL cell viability and suppressed proliferation, while miR-598-3p interference showed reversed effects. Additionally, the target gene of miR-598-3p, Dishevelled, EGL-10, and Pleckstrin domain-containing mTOR-interacting protein (DEPTOR), was down-regulated by miR- 598-3p in T-ALL. MiR-598-3p decreased phospho (p)-AKT protein expression, while AKT inhibition counteracted the suppressive effects of miR-598-3p silencing on T-ALL cell viability and proliferation.
Conclusion: MiR-598-3p/DEPTOR is involved in the proliferation of T-ALL through AKT pathway, thus providing a potential novel application in pediatric T-ALL.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
